Skip to content

Comparison of analgesic effect of butorphanol by patient-controlled intravenous analgesia combined with quadratus lumborum block or epidural morphine after cesarean section

Comparison of analgesic effect of butorphanol by patient-controlled intravenous analgesia combined with quadratus lumborum block or epidural morphine after cesarean section

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049020
Enrollment
Unknown
Registered
2021-07-19
Start date
2020-06-01
Completion date
Unknown
Last updated
2022-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

scheduled for cesarean section with scar uterus

Interventions

Group B:butorphanol PCIA combined with QLB
Group M:butorphanol PCIA combined with epidural morphine

Sponsors

Dept. of Anesthesiology, Longgang District People’s Hospital of Shenzhen
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: ASA physical status II, gestation 37-42 weeks, aged 25-40 years, body weight <90kg, no contraindication of spinal anesthesia, no recent history of taking psychiatric drugs or drug abuse, no serious complications of cardiovascular, cerebrovascular, liver and kidney diseases.

Exclusion criteria

Exclusion criteria: Combined spinal and epidural anesthesia fails or the upper boundary level of lumbar anesthesia is lower than T6, the operative duration is >90min, and anesthesia drugs are allergic

Design outcomes

Primary

MeasureTime frame
Visual analogue scale (VAS) was used to score postoperative pain in resting and motor states;

Secondary

MeasureTime frame
the effective pressing times of PCIA;the rate of rescue analgesia, and the degree of satisfaction with analgesic effect;

Countries

China

Contacts

Public ContactJi Hongxin

Longguang Distict People's Hospital of Shenzhen ?

hongxinji@163.com+86 0755-28932833-6301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026